About Audubon Bioscience
We began our journey in 2016 in the Audubon area (hence the name of the company) of New Orleans, LA, when Dr. Rostyslav Semikov started his postdoctoral fellowship research at the Louisiana State University Neuroscience Center.
In 2018 we moved our headquarters to Texas Medical Center in Houston, TX, and continued growing our operations globally. Today, Audubon Bioscience is a rapidly growing team of 70+ people globally committed to helping our partners succeed in their clinical research.
At Audubon Bioscience, our goal is to support cutting-edge cancer and precision medicine research to find new life-saving diagnostics and treatments. Quality biospecimens and their data are a critical part of achieving this goal, which is why we focus so much of our efforts on processes that ensure their viability and usability. Meeting our customers’ needs is the other critical component. By listening to and working extensively with each researcher, large or small, we ensure that you receive the right samples for your project at the right time.
We are working towards a world where cancer could be early detected and effectively treated. We strive to become the world’s best private biospecimen provider that fuels research that will make this vision a reality.
- Put customer first
- Build the best team in the industry
- Achieve quality and precision in everything
- Practice integrity and high ethical standards
We provide biospecimen solutions to cancer and precision medicine researchers to support discovery of new life-saving diagnostics and treatments
Global Network of Clinics
Audubon Bioscience procures biospecimens from our extensive network of 100+ clinical sites spread throughout the USA, Europe, Asia and Africa. Because we collect samples from around the globe, we are able to offer a tremendous variety of genetically diverse samples and hard-to-procure specimens, including samples that are treatment-naive and ethnicity-specific.